On September 29, 2020, Dr. Andrew Satlin notified Intra-Cellular Therapies, Inc. that he would resign from his position as Chief Medical Officer of the Company effective as of October 28, 2020 in order to pursue a new opportunity. Dr. Satlin will assist with the transition of his responsibilities through October 28, 2020. Dr. Satlin's resignation was not the result of any disagreement with the Company or its Board of Directors on any matter relating to the Company's operations, policies or practices. The company also announced the promotion of Dr. Suresh Durgam to the position of Chief Medical Officer. Additionally, Dr. Andrew Satlin will step down as Chief Medical Officer, and will leave the Company effective October 28, 2020 to pursue a new opportunity.